Atlanta Site Added to NIH Clinical Trial of a Vaccine for COVID-19 | NIH: National Institute of Allergy and Infectious Diseases

Atlanta Site Added to NIH Clinical Trial of a Vaccine for COVID-19 | NIH: National Institute of Allergy and Infectious Diseases

Atlanta Site Added to NIH Clinical Trial of a Vaccine for COVID-19

Friday, March 27, 2020

Emory University in Atlanta will begin enrolling healthy adult volunteers ages 18 to 55 years in a Phase 1 clinical trial of an investigational vaccine designed to prevent coronavirus disease 2019 (COVID-19). The trial, supported by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, began last week at Kaiser Permanente Washington Health Research Institute (KPWHRI) in Seattle. KPWHRI and Emory are part of NIAID’s Infectious Diseases Clinical Research Consortium. The trial will enroll a total of 45 people across the two sites.

Adults who are interested in joining this study should contact vaccine@emory.edu (for the Hope Clinic in Decatur) or ecc.vaccine@emory.edu (for the Emory campus in Atlanta). People who live outside of this region will not be eligible to participate in this trial.